weight · loss

Tesofensine

FDA: research-only

Tesofensine is an appetite modulator with nootropic-like properties that improves AMPK activation and blood sugar control. Originally developed for neurodegenerative diseases, it was found to have potent weight loss effects through triple monoamine reuptake inhibition. Triple monoamine reuptake inhibitor (serotonin, norepinephrine, dopamine) that acts as an appetite modulator. Improves AMPK activation and blood sugar control. Combats low dopamine drive, anhedonia, and burnout. Has nootropic-like properties alongside metabolic effects. - Appetite suppression - Metabolic control and insulin sensitivity - Dopamine restoration and motivation - Anti-anhedonia effects - Weight management - AMPK activation - Standard: 0.25-0.5 mg/day orally - Route: Oral -

This content is for educational and research purposes only. VialBase does not provide medical advice. Consult a healthcare professional before using any peptide.

Molecular weight
Half-life
CAS number
Route

Stacks containing Tesofensine

02

Sourcing

Current prices

Updated today

500mg

Only vendor stocking this size on the VialBase roster.

Stocks this compound Third-party tested Public COAs Positive rep

Save 15% with code VIALBASE at checkout

Stocks this compound Third-party tested Public COAs

VialBase may earn a commission on purchases through partner links — never at additional cost to you. Full disclosure.

Also vetted at
What bloodwork do I need?

Reference ranges are general guidelines. Consult your physician for interpretation.

PRE-CYCLE
  • CMP
  • CBC
  • Lipid Panel
  • Fasting Glucose
  • Fasting Insulin
  • Blood Pressure
  • Heart Rate
DURING CYCLE
  • CMP
  • Blood Pressure
  • Heart Rate
  • Fasting Glucose
POST-CYCLE
  • CMP
  • Lipid Panel
  • Blood Pressure
Safety & Regulatory Status
FDA STATUS research-only

Regulatory status for Tesofensine may change. Verify current status with your jurisdiction before use. This is not legal or medical advice.